Medication can play a huge role in reducing high blood pressure, a leading cause of stroke, heart attack and other serious health problems. Yet given the wide selection of drugs for doctors to choose from, figuring out which ...
Jun 25, 2019
0
1
A new study by Mayo Clinic researchers may have broad implications for treatment of patients with predominantly benign thyroid disease and newly treated hypothyroidism.
Jun 19, 2019
0
4
Patients with left-sided heart failure who get implanted devices to improve the pumping of their hearts may be more likely to develop heart failure on the opposite side of their hearts if they are pre-treated with off-label ...
Jun 11, 2019
0
0
(HealthDay)—People who use common heartburn drugs for months to years may face heightened risks of dying from heart disease, kidney failure or stomach cancer, a new study suggests.
Jun 6, 2019
0
32
The confluence of two major health crises—the opioid epidemic and organ shortage—has moved surgeons to consider transplanting organs deemed as less than "perfect" in an effort to expand the donor pool and save more lives, ...
Jun 6, 2019
1
10
Drug therapy for patients with stable heart failure can be simplified by stopping diuretics, according to late breaking results from the ReBIC-1 trial presented today at Heart Failure 2019, a scientific congress of the European ...
May 26, 2019
0
1
A potentially fatal buildup of abnormal proteins in the heart and other organs is being delayed in its diagnosis and undertreated—despite new drugs that can combat it, a new study suggests.
May 21, 2019
0
2
Results from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) rapidly and effectively reduces pressure and volume in the heart. This is the first study targeting the SVC as a therapeutic ...
May 21, 2019
0
1
Johns Hopkins Medicine researchers recently found a key structural differences in channels that regulate how and when heart and skeletal muscles contract. Identifying the differences between the two, say researchers, provides ...
May 15, 2019
0
0
A stroke treatment developed by researcher Byron Ford at the University of California, Riverside, has moved toward clinical trials.
May 9, 2019
0
3
